Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options

Back

ESC2025 Premium Access

Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options

Session: In-hospital care of acute heart failure

Topic: Pharmacotherapy

Speaker: Doctor S. Jimenez-Marrero (Barcelona, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Santiago Jimenez-Marrero

University Hospital of Bellvitge, Barcelona (Spain)

2 presentations

0 follower

7 more presentations in this session

Prognostic impact of urine output after catecholamine administration in cardiogenic shock due to acute decompensated heart failure

Speaker: Doctor S. Kawanami (Sakai, JP)

Impact of in-hospital initiation of angiotensin receptor-neprilysin inhibition on left ventricular reverse remodeling in acute heart failure: an insight from PREMIER trial

Speaker: Assistant Professor T. Takahashi (Tokushima, JP)

Impact and course of albuminuria in acute heart failure according to left or right sided heart failure phenotype

Speaker: Mr J. Deniz Rosario (Las Palmas de Gran Canaria, ES)

Prognostic value of energetic hemodynamics in acute heart failure: beyond conventional measures

Speaker: Doctor H. Chang (Taipei, TW)

Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0

Speaker: Doctor I. Leontsinis (Athens, GR)

Access the full session

In-hospital care of acute heart failure

Speakers: Doctor S. Jimenez-Marrero, Doctor S. Kawanami, Assistant Professor T. Takahashi, Mr J. Deniz Rosario, Doctor H. Chang...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources